N/A
Manufactured by AARNA USA INC.
52 FDA adverse event reports analyzed
Last updated: 2026-04-14
CHILDRENS ACETAMINOPHEN is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by AARNA USA INC.. The most commonly reported adverse reactions for CHILDRENS ACETAMINOPHEN include ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD, FAILURE OF CHILD RESISTANT MECHANISM FOR PHARMACEUTICAL PRODUCT, OFF LABEL USE, WEIGHT DECREASED, RESPIRATORY SYNCYTIAL VIRUS INFECTION. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for CHILDRENS ACETAMINOPHEN.
Out of 17 classified reports for CHILDRENS ACETAMINOPHEN:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.